Conversations in Healthcare
Possible treatment for COVID-19 related respiratory failure
Share this episode
Jonathan Javitt, CEO of NeuroRx, discusses his collaboration with Relief Therapeutics on Aviptadil, a synthetic version of vasoactive intestinal peptide, and a potential treatment of COVID-19 related respiratory failure.
Clarivate Conversations in Healthcare is a series of candid interviews with industry leaders and experts on the key trends and challenges that are shaping the future of the healthcare industry. Topics include from clinical innovation, deal-making, market access and regulatory dynamics, data and technology, new engagement models, patient centricity, diversity, COVID-19 and much more. Subscribe for episodes here.
